Auriga to make pSiMedica's BioSilicon tumour treatment
This article was originally published in Clinica
Executive Summary
BrachySil, a potential treatment for cancerous tumours being developed by UK biocompatible silicon firm pSiMedica, is to be manufactured by Auriga Medical under a new agreement.